| DENALI THERAPEUTICS |
| USA |
| Gesundheit |
| US24823R1059 / A2H9G8 |
| 4DN (Frankfurt) / DNLI (NASDAQ) |
| FRA:4DN, ETR:4DN, 4DN:GR, NASDAQ:DNLI |
| - |
| https://denalitherapeutic.. |
|
Denali Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing therapeutics to address neurodegenerative and lysosomal storage diseases. The company engineers product candidates using proprietary technologies such as An..
>Volltext.. |
| 2479.18 Mio. EUR |
| 1782.5 Mio. EUR |
| - |
| -469.7 Mio. EUR |
| -443.16 Mio. EUR |
| -2.57 EUR |
| 36.56 Mio. EUR |
| 177.53 Mio. EUR |
| -356.75 Mio. EUR |
| 8.82 |
| - |
| -6.86% |
| - |
| - |
| - |
| - |
| DENALI THERAPEUTICS, DENALI THERAPEUTIC |
| 02.04.26 |
|